Agustin Chicas
Jnana Therapeutics (United States)(US)Forma Therapeutics (United States)(US)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Cancer-related Molecular Pathways, Telomeres, Telomerase, and Senescence, RNA modifications and cancer, Epigenetics and DNA Methylation
Most-Cited Works
- → RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia(2011)1,858 cited
- → Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity(2011)968 cited
- → Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway(2012)853 cited
- → A Novel Role for High-Mobility Group A Proteins in Cellular Senescence and Heterochromatin Formation(2006)605 cited
- → BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance(2016)394 cited
- → Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence(2010)378 cited
- → Independence of Repressive Histone Marks and Chromatin Compaction during Senescent Heterochromatic Layer Formation(2012)309 cited
- → H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescence(2012)160 cited
- → Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A–SF3b complex(2017)148 cited
- → The atypical E2F family member E2F7 couples the p53 and RB pathways during cellular senescence(2012)133 cited